{"schema_version":"1","generated_at":"2026-11-08T00:39:18.928Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mary-knesevich","json_url":"https://www.findmykol.com/kol/mary-knesevich/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mary-knesevich","name":"Mary Knesevich","credential":"MD","specialty":"Psychiatry","specialty_raw":"Psychiatry","therapeutic_area":"Psychiatry","therapeutic_areas":["Psychiatry"],"city":"Dallas","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1033120811","openalex":"A5004498302"},"summary":"Mary Knesevich is a Psychiatry physician. OpenAlex indexes 13 publications with 910 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Psychiatry"]},"scholarship":{"works_count":13,"cited_by_count":910,"h_index":9,"latest_activity_year":2023,"source":"works"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":28,"shown":3,"withheld":25,"rows":[{"payer":"BioXcel Therapeutics","program_year":2025,"amount_usd":164861.76,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1033120811"},{"payer":"AbbVie","program_year":2025,"amount_usd":28210.93,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1033120811"},{"payer":"Bristol Myers Squibb","program_year":2025,"amount_usd":8360,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1033120811"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1033120811","source":"payments"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"OpenAlex author record","recent":[{"title":"KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia","year":2017,"journal":"American Journal of Psychiatry","source_url":"https://doi.org/10.1176/appi.ajp.2017.16091037","status":"verified"},{"title":"KINECT 3: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Valbenazine (NBI-98854) for Tardive Dyskinesia (PL02.003)","year":2016,"journal":"Neurology","source_url":"https://doi.org/10.1212/wnl.86.16_supplement.pl02.003","status":"verified"},{"title":"Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases","year":2013,"journal":"Neuropsychopharmacology","source_url":"https://doi.org/10.1038/npp.2013.111","status":"verified"},{"title":"Poster #175 ADJUNCTIVE LISDEXAMFETAMINE DIMESYLATE TREATMENTOF PREDOMINANT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN CLINICALLY STABLE ADULTS MAINTAINED ON ATYPICAL ANTIPSYCHOTIC AGENTS: A 14-WEEK TRIAL","year":2012,"journal":"Schizophrenia Research","source_url":"https://doi.org/10.1016/s0920-9964(12)70747-8","status":"verified"},{"title":"P.2.e.037 The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial","year":2009,"journal":"European Neuropsychopharmacology","source_url":"https://doi.org/10.1016/s0924-977x(09)70736-9","status":"verified"}],"source":"works"},"contact":{"address_1":"4600 SAMUELL BLVD","city":"Dallas","state":"TX","zip":"752286827","phone":"214-381-7181","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1033120811","source":"identity"},"similar":[{"name":"Charles Nemeroff","slug":"charles-nemeroff","institution":"Dell Medical School","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/charles-nemeroff","json_url":"https://www.findmykol.com/kol/charles-nemeroff/profile.json"},{"name":"Dennis Charney","slug":"dennis-charney","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/dennis-charney","json_url":"https://www.findmykol.com/kol/dennis-charney/profile.json"},{"name":"Maurizio Fava","slug":"maurizio-fava","institution":"Massachusetts General Hospital","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/maurizio-fava","json_url":"https://www.findmykol.com/kol/maurizio-fava/profile.json"},{"name":"John Krystal","slug":"john-krystal","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/john-krystal","json_url":"https://www.findmykol.com/kol/john-krystal/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":25,"publications":8}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-07-08","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}